The Prescription Drug Affordability Board posted the agenda for its next meeting on February 21. Ozempic, Trulicity and Shingrix are listed on the agenda for affordability review. Please register in advance of the meeting.
Also in Oregon, the Board of Pharmacy posted the agenda and meeting materials for its special board meeting on February 23.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.